| 前收市價 | 245.60 |
| 開市 | 246.60 |
| 買盤 | 246.40 x 0 |
| 賣出價 | 250.00 x 0 |
| 今日波幅 | 246.60 - 249.10 |
| 52 週波幅 | 161.40 - 257.50 |
| 成交量 | |
| 平均成交量 | 0 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
- Benzinga
Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories
Reuters Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move to the private sector from the government. "There are different customers negotiating different prices right now, which is why it's a little bit complicated," the company's president Stephen Hoge said in an interview ahead of a Congressional hearing run by Democratic U.S. Senator Bernie Sanders on Moderna's pricing plans. EU Co
- Benzinga
Ferrari's Italian Subsidiary Hit By Ransomware Comprising Client Data, Taps Cybersecurity Expert To Investigate
Ferrari NV's (NYSE: RACE) Italian subsidiary Ferrari SpA suffered a ransomware attack on March 20. Ferrari immediately started an investigation by tapping a leading global third-party cybersecurity firm. Ferrari also informed the relevant authorities. Also Read: Microsoft Cautions Against More Russia Led Ransomware Attack Ferrari informed its clients and customers of the potential data exposure and the nature of the incident. Ferrari confirmed the breach had no impact on its company's operationa
- InvestorPlace
3 Stocks That Morgan Stanley Is Betting On Right Now
It’s not exactly easy for investors out there right now. For starters, there’s the current market turmoil surrounding the collapse of a number of regional banks. As if we needed that on top of the uncertainty over the direction of the broader economy and Federal Reserve interest rate policy. The recent volatility makes good stock picking all the more important. And if you can lean on research from one of the top investment banks in the world, why wouldn’t you? After all, there are no prizes for
